Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.300
-0.090 (-3.77%)
At close: Nov 13, 2026, 4:00 PM EST
2.300
0.00 (0.00%)
After-hours: Nov 13, 2026, 5:43 PM EST
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $256.82 million as of November 13, 2026. It is the 18,872nd most valuable company in the world and the 3,303rd biggest in the United States. Its market cap has decreased by 28.08% in one year.
Market Cap
256.82M
Enterprise Value
42.35M
1-Year Change
-28.08%
Global Rank
Country Rank
#3,303 United States
Category
ChartMarket Cap Chart
Since February 18, 2015, Rocket Pharmaceuticals's market cap has increased from $95.30M to $256.82M, an increase of 169.48%. That is a compound annual growth rate of 8.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 256.82M | -32.40% |
| Dec 31, 2025 | 379.90M | -66.84% |
| Dec 31, 2024 | 1.15B | -57.60% |
| Dec 29, 2023 | 2.70B | 82.44% |
| Dec 30, 2022 | 1.48B | 5.28% |
| Dec 31, 2021 | 1.41B | -53.56% |
| Dec 31, 2020 | 3.03B | 164.17% |
| Dec 31, 2019 | 1.15B | 94.21% |
| Dec 31, 2018 | 590.40M | 730.38% |
| Dec 29, 2017 | 71.10M | -56.73% |
| Dec 30, 2016 | 164.30M | -45.09% |
| Dec 31, 2015 | 299.20M | 213.96% |
| Feb 18, 2015 | 95.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 266.66M |
| Q32 Bio | 260.64M |
| Faeth Therapeutics | 259.18M |
| Protalix BioTherapeutics | 257.17M |
| Inovio Pharmaceuticals | 256.89M |
| Clinuvel Pharmaceuticals | 253.61M |
| Vogenx | 247.63M |
| vTv Therapeutics | 245.01M |